Skip to content
10-K

Annual Report

AKARI THERAPEUTICS, PLC AKTX

0001493152-26-013664

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 1, 2026 91.57B sh
Shares Diluted FY 2025 · Dec 31, 2025 67.33B sh
Shares Diluted FY 2025 · Dec 31, 2024 23.89B sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$10.57M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$12.55M
Cash And Equivalents FY 2025 · Dec 31, 2025 $0
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $0
Stockholders Equity FY 2025 · Dec 31, 2025 $28.33M
Stockholders Equity FY 2025 · Dec 31, 2024 $22.23M
Stockholders Equity FY 2025 · Dec 31, 2023 −$229K
Current Liabilities FY 2025 · Dec 31, 2025 $12.35M
Current Liabilities FY 2025 · Dec 31, 2024 $19.91M
Total Liabilities FY 2025 · Dec 31, 2025 $19.56M
Total Liabilities FY 2025 · Dec 31, 2024 $28.33M
Current Assets FY 2025 · Dec 31, 2025 $5.46M
Current Assets FY 2025 · Dec 31, 2024 $2.95M
Total Assets FY 2025 · Dec 31, 2025 $47.89M
Total Assets FY 2025 · Dec 31, 2024 $50.56M
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 $0.00
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 $0.00
Sga Expense FY 2025 · Dec 31, 2025 $9.28M
Sga Expense FY 2025 · Dec 31, 2024 $9.66M
Rd Expense FY 2025 · Dec 31, 2025 $2.82M
Rd Expense FY 2025 · Dec 31, 2024 $6.98M
Net Income FY 2025 · Dec 31, 2025 −$17.3M
Net Income FY 2025 · Dec 31, 2024 −$19.79M
Operating Income FY 2025 · Dec 31, 2025 −$17.28M
Operating Income FY 2025 · Dec 31, 2024 −$21.64M